로마 기준 IV 이해하기: 과민성 장증후군과 기능성 설사
Understanding the Rome IV: Irritable Bowel Syndrome and Functional Diarrhea
1
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Irritable bowel syndrome (IBS) is a common, chronic functional gastrointestinal disorder affecting the large intestine, and presents as abdominal pain and/or discomfort, bloating, gas retention, diarrhea, and constipation. IBS impairs quality-of-life and requires long-term management. In 2016, the Rome Foundation introduced new IBS diagnostic criteria (the Rome IV criteria), and also revised the diagnostic algorithms for, and the multidimensional clinical profile (MDCP) of, functional gastrointestinal disorders. The IBS MDCP includes clinical data, the extent to which normal daily activities are affected, and psychosocial and physiological measures. The criteria seek to aid physicians in choosing appropriate treatment for IBS patients. Herein, we seek to provide evidence- based practical information on IBS and functional diarrhea. We review the new Rome diagnostic IV criteria, the MDCP, and the various IBS treatment options. We suggest that, in clinical practice, combination therapies may be useful to treat patients with IBS of various grades.
Abstract
Irritable bowel syndrome (IBS) is a common, chronic functional gastrointestinal disorder affecting the large intestine, and presents as abdominal pain and/or discomfort, bloating, gas retention, diarrhea, and constipation. IBS impairs quality-of-life and requires long-term management. In 2016, the Rome Foundation introduced new IBS diagnostic criteria (the Rome IV criteria), and also revised the diagnostic algorithms for, and the multidimensional clinical profile (MDCP) of, functional gastrointestinal disorders. The IBS MDCP includes clinical data, the extent to which normal daily activities are affected, and psychosocial and physiological measures. The criteria seek to aid physicians in choosing appropriate treatment for IBS patients. Herein, we seek to provide evidence- based practical information on IBS and functional diarrhea. We review the new Rome diagnostic IV criteria, the MDCP, and the various IBS treatment options. We suggest that, in clinical practice, combination therapies may be useful to treat patients with IBS of various grades.
참고문헌 (15)
- Kasper D, "Harrison's principles of internal medicine", pp.1965~1970 (2016), McGraw-Hill
- Chey WD, "Irritable bowel syndrome:a clinical review", JAMA, 313, pp.949~958 (2015)
- 김재학, "Biomarkers of Irritable Bowel Syndrome", Journal of Neurogastroenterology and Motility (JNM), 23(1), pp.20~26 (2017), 대한소화기 기능성질환∙운동학회[DOI]
- Brandt LJ, "An evidence-based position statement on the management of irritable bowel syndrome", Am J Gastroenterol, 104(Suppl 1), pp.S1~S35 (2009)
- Lee SY, "Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study", Digestion, 79, pp.196~201 (2009)
- Dong Won Park, "The Differences in Prevalence and Sociodemographic Characteristics of Irritable Bowel Syndrome According to Rome II and Rome III", Journal of Neurogastroenterology and Motility (JNM), 16(2), pp.186~193 (2010), 대한소화기 기능성질환∙운동학회
- Rome Foundation, "Guidelines--Rome III diagnostic criteria for functional gastrointestinal disorders", J Gastrointestin Liver Dis, 15, pp.307~312 (2006)
- Palsson OS, "Development and validation of the Rome IV diagnostic questionnaire for adults", Gastroenterology, 150, pp.1481~1491 (2016)
- Drossman DA, "Rome IV-functional GI disorders:disorders of gut-brain interaction", Gastroenterology, 150, pp.1257~1261 (2016)
- Begtrup LM, "A positive diagnostic strategy is noninferior to a strategy of exclusion for patients with irritable bowel syndrome", Clin Gastroenterol Hepatol, 11, pp.956~962 (2013)
- "Rome IV FAQs" (2017)[URL]
- Patel P, "Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey", Scand J Gastroenterol, 50, pp.816~823 (2015)
- Kellow J, "Diagnostic algorithms for common GI symptoms" (2016), Rome foundation
- Drossman DA, "Multidimensional Clinical Profile for Functional Gastrointestinal Disorders" (2016), Rome foundation
- Lucak S, "Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice", Therap Adv Gastroenterol, 10, pp.253~275 (2017)